Adverse cardiovascular events in acute coronary syndrome with indications for anticoagulation

Conclusions:
In this real world observational study, the at-discharge AT strategy was not significantly associated with the 2-year risk of MACE. These findings do not negate the need for randomized trials to generate evidence-based approaches to management of this important population.

Source: Therapeutic Advances in Cardiovascular Disease - July 7, 2016 Category: Cardiology Authors: Knight, S., McCubrey, R. O., Yuan, Z., Woller, S. C., Horne, B. D., Bunch, T. J., Le, V. T., Mills, R. M., Muhlestein, J. B. Tags: Original Research Source Type: research